CN1483454A - Medicine for treating cardio-cerebral vascular diseases - Google Patents
Medicine for treating cardio-cerebral vascular diseases Download PDFInfo
- Publication number
- CN1483454A CN1483454A CNA031355153A CN03135515A CN1483454A CN 1483454 A CN1483454 A CN 1483454A CN A031355153 A CNA031355153 A CN A031355153A CN 03135515 A CN03135515 A CN 03135515A CN 1483454 A CN1483454 A CN 1483454A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- grams
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese medicine for curing angiocardiopathy and cerebrovascular diseases, such as cerebral thrombosis, coronary heart disease, cardiac infarction and apoplexia with obvious therapeutic effect. Said Chinese medicine is made of 18 Chinese medicinal materials of nanbuzheng, moutan root bark, Chinese angelica root, phellodendron bark, clematis root and others.
Description
Technical field: the present invention relates to a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, particularly a kind of medicine of Chinese herbal treatment cardiovascular and cerebrovascular disease belongs to the Chinese herbal and crude drugs preparations field.
Background technology: cardiovascular and cerebrovascular disease has become commonly encountered diseases, the frequently-occurring disease of middle-aged and elderly people, the treatment cardiovascular and cerebrovascular disease adopts western medical treatment more at present, though energy is mitigate the disease in time, but simultaneously also be easy to generate side effect for the patient that other disease is arranged, curative effect such as common treatment Chinese Traditional Medicines such as BUCHANG NAOXINTONG, Limitation-or-qualification trematodiasis network reach, snowy region is just collapsing treasured is also not satisfactory.
Summary of the invention: the medicine that the object of the present invention is to provide the treatment cardiovascular and cerebrovascular disease of a kind of heat-clearing and toxic substances removing, removing heat from blood blood vessel dilating, collateral dredging spasmolytic, treating both the principal and the secondary aspects of a disease at the same time.
The present invention is achieved in that it is by NANBUZHENG, Cortex Moutan, Radix Angelicae Sinensis, Cortex Phellodendri, Radix Clematidis, Herba Epimedii, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Radix Morindae Officinalis, Radix Codonopsis, Spica Prunellae, Radix Salviae Miltiorrhizae, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Osmundae, Rhizoma Chuanxiong, Caulis Spatholobi, Rhizoma Curculiginis 18 flavor prepared from traditional Chinese medicines form, and each Chinese herbal medicine of distinguishing the flavor of is respectively by weight ratio: NANBUZHENG 10---and 40 parts, Cortex Moutan 5---20 parts, Radix Angelicae Sinensis 5---25 parts, Cortex Phellodendri 3---20 parts, Radix Clematidis 5---20 parts, Herba Epimedii 5---25 parts, Radix Achyranthis Bidentatae 10---40 parts, Radix Paeoniae Rubra 5---20 parts, Radix Morindae Officinalis 5---30 parts, Radix Codonopsis 4---40 parts, Spica Prunellae 5---25 parts, Radix Salviae Miltiorrhizae 5---20 parts, the Rhizoma Anemarrhenae 5---20 parts, the Radix Astragali 15---40 parts, Rhizoma Osmundae 5---20 parts, Rhizoma Chuanxiong 5---25 parts, Caulis Spatholobi 10---40 parts, Rhizoma Curculiginis 5---25 parts.
Owing to adopt technique scheme, the present invention compared with prior art has effects such as heat-clearing and toxic substances removing, removing heat from blood blood vessel dilating, blood pressure lowering, haemolysis fat, thrombus dissolving, collateral dredging spasmolytic, for diseases such as cerebral thrombosis, coronary heart disease, myocardial infarction, apoplectic hemiplegia significant curative effect is arranged.
Through 100 many cases to the mean age 50---the treatment of 80 years old Middle Age and Aged Patients is observed, and all is the patients that suffer from cardiovascular and cerebrovascular disease for a long time, and some is long-term hemiplegic patient, and through taking medicine of the present invention, the state of an illness has very big improvement.
As patient week so-and-so, the woman, 75 years old, hypertension caused apoplexy, collapses from physical exhaustion, western medical treatment does not have improvement, through taking this medicine, all defensive positions, foot are strong, connect and eat 25 days medicines, disease heals entirely;
Patient Yang, the man, 73 years old, hypertension caused cerebral thrombosis, integrative therapy four months, unsatisfactory curative effect is through taking medicine of the present invention, basic rehabilitation after 30 days;
Patient Lu so-and-so, the woman suffered from apoplexy sequela in 1998, the trick inertia, this patient takes an evident turn for the better after 20 days through taking medicine of the present invention, continues to take this medicine and fully recovers after 15 days.
Patient Huang, the man, hypertension causes hemiplegia before 5 years, through western medical treatment, takes medicines such as step-length nicergoline again for a long time, and unsatisfactory curative effect helps walking with crutch always, and after taking medicine of the present invention, after one month, hemiplegia is cured, and walking is without crutch.
The treatment cardiovascular and cerebrovascular disease is taken this medicine, and light disease 10-20 days is effective in cure, and middle disease 20---40 days are effective in cure, serious symptom 40 days---got final product rehabilitation in 80 days.
The specific embodiment:
Embodiment 1: getting Radix Angelicae Sinensis 25 gram earlier, to be ground into fine powder standby, selection NANBUZHENG 40 grams, Cortex Moutan 20 grams, Cortex Phellodendri 20 grams, Radix Clematidis 20 grams, Herba Epimedii 25 grams, Radix Achyranthis Bidentatae 40 grams, 20 parts of grams of Radix Paeoniae Rubra, Radix Morindae Officinalis 30 grams, Radix Codonopsis 40 grams, Spica Prunellae 25 grams, Radix Salviae Miltiorrhizae 20 grams, the Rhizoma Anemarrhenae 20 grams, the Radix Astragali 40 grams, Rhizoma Osmundae 20 grams, Rhizoma Chuanxiong 25 grams, Caulis Spatholobi 40 grams, Rhizoma Curculiginis 25 grams are cleaned, water decocts twice, each 2 hours, merge and the filtration decoction liquor, it is 1.30 extractum that filtrate after merging is concentrated under 80 ℃ of temperature proportion, to carry out drying behind this extractum and the Radix Angelicae Sinensis fine powder mix homogeneously, the amount by every 0.5 gram of again it being ground into behind the coarse powder incapsulates and gets product.One day three times, each 6.
Embodiment 2: selection NANBUZHENG 10 grams, Cortex Moutan 5 grams, Radix Angelicae Sinensis 5 grams, Cortex Phellodendri 3 grams, Radix Clematidis 5 grams, Herba Epimedii 5 grams, Radix Achyranthis Bidentatae 10 grams, Radix Paeoniae Rubra 5 grams, Radix Morindae Officinalis 5 grams, Radix Codonopsis 4 grams, Spica Prunellae 5 grams, Radix Salviae Miltiorrhizae 5 grams, the Rhizoma Anemarrhenae 5 grams, the Radix Astragali 15 grams, Rhizoma Osmundae 5 grams, Rhizoma Chuanxiong 5 grams, Caulis Spatholobi 10 grams, Rhizoma Curculiginis 5 grams, the little fire of reuse was fried in shallow oil 20 minutes after water was fried boiling, decoct three times, merge three times decoction liquor, took one day 3 times 2 days.
Claims (1)
1, a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, it is characterized in that: it is by NANBUZHENG, Cortex Moutan, Radix Angelicae Sinensis, Cortex Phellodendri, Radix Clematidis, Herba Epimedii, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Radix Morindae Officinalis, Radix Codonopsis, Spica Prunellae, Radix Salviae Miltiorrhizae, the Rhizoma Anemarrhenae, the Radix Astragali, Rhizoma Osmundae, Rhizoma Chuanxiong, Caulis Spatholobi, Rhizoma Curculiginis 18 flavor prepared from traditional Chinese medicines form, and each Chinese herbal medicine of distinguishing the flavor of is respectively by weight ratio: NANBUZHENG 10---and 40 parts, Cortex Moutan 5---20 parts, Radix Angelicae Sinensis 5---25 parts, Cortex Phellodendri 3---20 parts, Radix Clematidis 5---20 parts, Herba Epimedii 5---25 parts, Radix Achyranthis Bidentatae 10---40 parts, Radix Paeoniae Rubra 5---20 parts, Radix Morindae Officinalis 5---30 parts, Radix Codonopsis 4---40 parts, Spica Prunellae 5---25 parts, Radix Salviae Miltiorrhizae 5---20 parts, the Rhizoma Anemarrhenae 5---20 parts, the Radix Astragali 15---40 parts, Rhizoma Osmundae 5---20 parts, Rhizoma Chuanxiong 5---25 parts, Caulis Spatholobi 10---40 parts, Rhizoma Curculiginis 5---25 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03135515 CN1216633C (en) | 2003-07-29 | 2003-07-29 | Medicine for treating cardio-cerebral vascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03135515 CN1216633C (en) | 2003-07-29 | 2003-07-29 | Medicine for treating cardio-cerebral vascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1483454A true CN1483454A (en) | 2004-03-24 |
| CN1216633C CN1216633C (en) | 2005-08-31 |
Family
ID=34154673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03135515 Expired - Fee Related CN1216633C (en) | 2003-07-29 | 2003-07-29 | Medicine for treating cardio-cerebral vascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1216633C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108079169A (en) * | 2017-12-20 | 2018-05-29 | 无锡市中医医院 | For preventing and treating the Chinese medicine composition of atherosclerosis and its complication, Chinese medicine preparation and application |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939435B (en) * | 2006-09-27 | 2010-11-10 | 杭州民生药业有限公司 | Hypolipidemic composition and its use |
-
2003
- 2003-07-29 CN CN 03135515 patent/CN1216633C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108079169A (en) * | 2017-12-20 | 2018-05-29 | 无锡市中医医院 | For preventing and treating the Chinese medicine composition of atherosclerosis and its complication, Chinese medicine preparation and application |
| CN108079169B (en) * | 2017-12-20 | 2021-01-05 | 无锡市中医医院 | Traditional Chinese medicine composition for preventing and treating atherosclerosis and complications thereof, traditional Chinese medicine preparation and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1216633C (en) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN102166278B (en) | Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof | |
| CN104258350A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome and preparation method of traditional Chinese medicine preparation | |
| CN101401927B (en) | Chinese medicine powder for treating apoplexy | |
| CN1145240A (en) | Medicinal compsn. for prevention of Aids virus and cancer | |
| CN1127967C (en) | Quick-acting hypertension capsule | |
| CN1053189A (en) | The preparation method of " promoting blood circulation and restoring paralysis pills " | |
| CN104042673A (en) | Traditional Chinese medicinal capsule for treating hypertension and preparation method thereof | |
| CN104257816B (en) | A kind of composition for treating berloque dermatitis and preparation method thereof | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN1228063C (en) | Medicine for treating liver disease | |
| CN105395755A (en) | Internal medicine for treating allergic rhinitis | |
| CN1077896A (en) | Medicine for psoriasis and manufacture method | |
| CN1216633C (en) | Medicine for treating cardio-cerebral vascular diseases | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1175461A (en) | Medicine composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof | |
| CN107397806B (en) | Medicine for treating rheumatic arthralgia and preparation method thereof | |
| CN105213537A (en) | A kind of pharmaceutical composition for the treatment of congestive heart failure | |
| CN105194296A (en) | Medicine composition for treating heart diseases | |
| CN1115162C (en) | Pure traditional Chinese medicine for treating hyperosteogeny and preparation process thereof | |
| CN1415360A (en) | Chinese traditional medicine for curing hemiparalysis caused by apoplexia and its preparation method | |
| CN105106540A (en) | Medicinal preparation for treating cerebral thrombosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050831 Termination date: 20110729 |